Quantitative reverse transcriptase polymerase chain reaction for prostate-specific antigen mRNA

被引:16
作者
Galvan, B [1 ]
Christopoulos, TK [1 ]
机构
[1] UNIV WINDSOR,DEPT CHEM & BIOCHEM,WINDSOR,ON N9B 3P4,CANADA
基金
加拿大自然科学与工程研究理事会;
关键词
prostate-specific antigen; mRNA; quantitative reverse transcriptase-polymerase chain reaction; time-resolved fluorometry;
D O I
10.1016/S0009-9120(97)00010-6
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Objective: To develop a quantitative reverse transcriptase-polymerase chain reaction assay for monitoring the prostate-specific antigen (PSA) mRNA. Methods: PSA mRNA is amplified, in parallel, with the mRNA of beta-actin, a housekeeping gene. The ratio of the amplification products obtained reflects the relative amount of PSA mRNA with respect to actin mRNA. During PCR, digoxigenin-dUTP is incorporated in the amplified sequences. The PCR products are analyzed separately by time-resolved immunofluorometric hybridization assays, using specific probes immobilized in microtiter wells. The hybrids are reacted with alkaline phosphatase-labeled anti-digoxigenin antibody. The phosphate ester of fluorosalicylate is used as a substrate. The fluorosalicylate produced forms a fluorescent complex with Tb3+-EDTA which is measured by time-resolved fluorometry. Results: The hybridization assays for both PSA and actin amplification products show linearity in the range of 1.4-110 pmol/L. The exponential phase of PCR amplification extends up to 200,000 and 100,000 PSA and actin cDNA molecules, respectively. We prepared mixtures containing various numbers of LNCaP cells in one million cells that do not express PSA and used them as samples in the proposed assay. The ratio of the fluorescence values obtained after analysis of PSA and actin amplification products is linearly related to the number of LNCaP cells in the range of 20 to 3000 cells. Reproducibility studies demonstrate %CVs for the fluorescence ratios of 14.7, 11.8, and 12.2 when samples containing 150, 300 and 1600 LNCaP cells were analyzed (n = 4). Conclusions: A quantitative analytical methodology is provided for monitoring PSA mRNA. The assay is expected to be beneficial in the study of prostate cancer spread.
引用
收藏
页码:391 / 397
页数:7
相关论文
共 32 条
  • [1] CANCER STATISTICS, 1994
    BORING, CC
    SQUIRES, TS
    TONG, T
    MONTGOMERY, S
    [J]. CA-A CANCER JOURNAL FOR CLINICIANS, 1994, 44 (01) : 7 - 26
  • [2] EPIDEMIOLOGIC EVIDENCE REGARDING PREDISPOSING FACTORS TO PROSTATE-CANCER
    CARTER, BS
    CARTER, HB
    ISAACS, JT
    [J]. PROSTATE, 1990, 16 (03) : 187 - 197
  • [3] CHOMCZYNSKI P, 1993, BIOTECHNIQUES, V15, P532
  • [4] ENZYMATICALLY AMPLIFIED TIME-RESOLVED FLUORESCENCE IMMUNOASSAY WITH TERBIUM CHELATES
    CHRISTOPOULOS, TK
    DIAMANDIS, EP
    [J]. ANALYTICAL CHEMISTRY, 1992, 64 (04) : 342 - 346
  • [5] MAXIMIZING SENSITIVITY AND SPECIFICITY OF PCR BY PREAMPLIFICATION HEATING
    DAQUILA, RT
    BECHTEL, LJ
    VIDELER, JA
    ERON, JJ
    GORCZYCA, P
    KAPLAN, JC
    [J]. NUCLEIC ACIDS RESEARCH, 1991, 19 (13) : 3749 - 3749
  • [6] DEGUCHI T, 1993, CANCER RES, V53, P5350
  • [7] DIAMANDIS EP, 1995, CLIN CHEM, V41, P177
  • [8] NEW BIOLOGICAL FUNCTIONS OF PROSTATE-SPECIFIC ANTIGEN
    DIAMANDIS, EP
    YU, H
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1995, 80 (05) : 1515 - 1517
  • [9] EPSTEIN JI, 1993, CANCER-AM CANCER SOC, V71, P3582, DOI 10.1002/1097-0142(19930601)71:11<3582::AID-CNCR2820711120>3.0.CO
  • [10] 2-Y